1. Scrip

Podcast: IQVIA Biotech’s Sockalingam On Clinical Research Virtualization In APAC

 
• By Anju Ghangurde

In this audio interview, the head of IQVIA Biotech (Japan-Asia Pacific) talks to Scrip on a range of aspects around digitalization and virtualization of clinical research in the region, including sharply reduced site contracting timelines. He also touches on the digital product launch efforts that are currently a reality in several markets.

Scrip Podcast Special
Trends in clinical research in Japan, Asia-Pacific • Source: Alamy

Dr Senthil Sockalingam, head, IQVIA Biotech, Japan-Asia Pacific (JAPAC) and chief medical officer, APAC, spoke to Scrip on trends and opportunities in the clinical research segment, partnering/outsourcing approaches and digitalization efficiencies, driven by the pandemic.

Rapid "virtualization" of the trials segment, how the regulatory framework in certain APAC markets is still catching up in this area, and adoption of telemedicine are some of

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Focus On Asia

More from Scrip

Finance Watch: Deerfield Closes $600m-Plus VC Fund; Gates Speeds Up Health Investments

 
• By Mandy Jackson

Private Company Edition: Deerfield’s third innovations fund will back therapeutics and other opportunities, the Gates Foundation – a sometimes funder of biotech firms – will spend $200bn over the next 20 years, and NewLimit raised a $130m series B round, among other financings.

Pipeline Watch: Six Approvals And Thirteen Phase III Readouts

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pharma Left Hanging After US/UK Trade Pact

 
• By Kevin Grogan

An ‘historic economic prosperity deal’ does not include the sector.